| Company Name: |
SPIRO PHARMA |
| Tel: |
|
| Email: |
eric_feng1954@126.com |
|
| | 4-(Azetidin-3-yl)-2,2-diMethylMorpholine ditrifluoroacetate Basic information |
| Product Name: | 4-(Azetidin-3-yl)-2,2-diMethylMorpholine ditrifluoroacetate | | Synonyms: | [(2R)-1-METHYLAZETIDIN-2-YL]METHANAMINE;4-(Azetidin-3-yl)-2,2-diMethylMorpholine ditrifluoroacetate;4-(azetidin-3-yl)-2,2-dimethylmorpholine;bis(trifluoroacetic acid);4-(Azetidin-3-yl)-2,2-dimethylmorpholine bis(2,2,2-trifluoroacetate);2-(3-aminoazetidin-1-yl)acetic acid;4-(Azetidin-3-yl)-2,2-dimethylmorpholine bis(trifluoroacetate);1-({4-methyl-2-oxabicyclo[2.1.1]hexan-1-yl}methyl
)piperazine | | CAS: | 1523606-35-0 | | MF: | C13H20F6N2O5 | | MW: | 398.2987192 | | EINECS: | | | Product Categories: | | | Mol File: | 1523606-35-0.mol |  |
| | 4-(Azetidin-3-yl)-2,2-diMethylMorpholine ditrifluoroacetate Chemical Properties |
| storage temp. | Store at 0-8 °C | | Appearance | light yellow solid |
| | 4-(Azetidin-3-yl)-2,2-diMethylMorpholine ditrifluoroacetate Usage And Synthesis |
| | 4-(Azetidin-3-yl)-2,2-diMethylMorpholine ditrifluoroacetate Preparation Products And Raw materials |
|